{{Rsnum
|rsid=884115
|Gene=PTGES2
|Chromosome=9
|position=128125577
|Orientation=plus
|GMAF=0.2525
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=PTGES2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.8 | 20.4 | 0.9
| HCB | 73.5 | 22.8 | 3.7
| JPT | 58.9 | 34.8 | 6.2
| YRI | 6.8 | 49.7 | 43.5
| ASW | 22.8 | 52.6 | 24.6
| CHB | 73.5 | 22.8 | 3.7
| CHD | 74.1 | 24.1 | 1.9
| GIH | 49.5 | 42.6 | 7.9
| LWK | 6.4 | 39.1 | 54.5
| MEX | 73.2 | 26.8 | 0.0
| MKK | 20.5 | 51.3 | 28.2
| TSI | 73.5 | 25.5 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19371221
|Title=Association analysis between the prostaglandin E synthase 2 R298H polymorphism and body mass index in 8079 participants of the KORA study cohort
}}

{{PMID Auto
|PMID=17566096
|Title=Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}